Debt-to-equity of Pacira BioSciences, Inc. from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pacira BioSciences, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 91%, a 0.08% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 91% -0.07% -0.08% 31 Dec 2025
Q3 2025 95% +8.6% +9.9% 30 Sep 2025
Q2 2025 101% +18% +22% 30 Jun 2025
Q1 2025 97% +14% +16% 31 Mar 2025
Q4 2024 91% +2.7% +3.1% 31 Dec 2024
Q3 2024 87% -11% -11% 30 Sep 2024
Q2 2024 83% -25% -23% 30 Jun 2024
Q1 2024 83% -34% -29% 31 Mar 2024
Q4 2023 88% -45% -34% 31 Dec 2023
Q3 2023 97% -53% -35% 30 Sep 2023
Q2 2023 108% -34% -24% 30 Jun 2023
Q1 2023 117% -16% -12% 31 Mar 2023
Q4 2022 134% +17% +14% 31 Dec 2022
Q3 2022 151% +55% +57% 30 Sep 2022
Q2 2022 142% +41% +41% 30 Jun 2022
Q1 2022 134% +26% +25% 31 Mar 2022
Q4 2021 117% +4.2% +3.7% 31 Dec 2021
Q3 2021 96% -24% -20% 30 Sep 2021
Q2 2021 101% -26% -21% 30 Jun 2021
Q1 2021 107% -22% -17% 31 Mar 2021
Q4 2020 113% -17% -13% 31 Dec 2020
Q3 2020 120% -5% -4% 30 Sep 2020
Q2 2020 127% +6.2% +5.2% 30 Jun 2020
Q1 2020 129% +11% +9.1% 31 Mar 2020
Q4 2019 130% +10% +8.6% 31 Dec 2019
Q3 2019 125% +2.8% +2.3% 30 Sep 2019
Q2 2019 121% -3.4% -2.7% 30 Jun 2019
Q1 2019 118% -8.7% -6.8% 31 Mar 2019
Q4 2018 119% -7.5% -5.9% 31 Dec 2018
Q3 2018 122% +5% +4.3% 30 Sep 2018
Q2 2018 124% +19% +18% 30 Jun 2018
Q1 2018 127% +37% +41% 31 Mar 2018
Q4 2017 127% +51% +66% 31 Dec 2017
Q3 2017 117% +41% +54% 30 Sep 2017
Q2 2017 105% +29% +39% 30 Jun 2017
Q1 2017 90% +13% +17% 31 Mar 2017
Q4 2016 76% -3.1% -3.9% 31 Dec 2016
Q3 2016 76% -6.4% -7.8% 30 Sep 2016
Q2 2016 76% -12% -13% 30 Jun 2016
Q1 2016 77% -14% -16% 31 Mar 2016
Q4 2015 79% -34% -30% 31 Dec 2015
Q3 2015 82% -63% -43% 30 Sep 2015
Q2 2015 87% -104% -54% 30 Jun 2015
Q1 2015 91% -178% -66% 31 Mar 2015
Q4 2014 113% -109% -49% 31 Dec 2014
Q3 2014 145% -21% -13% 30 Sep 2014
Q2 2014 191% +70% +58% 30 Jun 2014
Q1 2014 269% +185% +219% 31 Mar 2014
Q4 2013 222% +149% +202% 31 Dec 2013
Q3 2013 166% +80% +94% 30 Sep 2013
Q2 2013 121% +0.25% +0.21% 30 Jun 2013
Q1 2013 84% -120% -59% 31 Mar 2013
Q4 2012 73% 31 Dec 2012
Q3 2012 86% 30 Sep 2012
Q2 2012 121% 30 Jun 2012
Q1 2012 204% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.